Adlai Nortye ANL
NASDAQ ANL
$15.01 +0.26 (+1.76%)
At close: Sep 4, 2026 · 4:00 PM EDT

Adlai Nortye (ANL) Invested Capital (2022 - 2026)

Adlai Nortye (ANL) posted quarterly Invested Capital of $26.7 million for Q4 2025, down 2.26% year-over-year from $27.4 million in Q4 2024, and down 39.3% quarter-over-quarter from $44.1 million in Q2 2025.

Analysis

Adlai Nortye (ANL) Invested Capital (2022 - 2026) Analysis & Trends

Adlai Nortye (ANL) has reported Invested Capital for 4 consecutive years, with $26.7 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Invested Capital fell 2.26% year-over-year to $26.7 million; the TTM figure through Dec 2025 stood at $137.0 million (down 65.29% YoY), while the FY2025 annual figure was $26.7 million, down 2.26% from the prior year.
  • Invested Capital eased to $26.7 million in Q4 2025 per ANL's latest filing, from $44.1 million in the prior quarter.
  • Across five years, Invested Capital topped out at $296.9 million in Q4 2022 and bottomed at $26.7 million in Q4 2025.
  • Historically, Invested Capital has averaged $77.6 million across 4 years, with a median of $35.3 million in 2023.
  • Annual changes were most pronounced in 2023 — Invested Capital plunged 89.34% — and 2025, when it gained 13.27%.
  • Adlai Nortye's Invested Capital stood at $296.9 million in 2022, then slumped by 89.34% to $31.7 million in 2023, then slipped by 13.58% to $27.4 million in 2024, then decreased by 2.26% to $26.7 million in 2025.
  • Business Quant data shows ANL's Invested Capital at $26.7 million in Q4 2025, $44.1 million in Q2 2025, and $27.4 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 33.70 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 7.35 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 6.25 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.13 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.30 Bn
10 Adlai Nortye 500.08 Mn 268.19 Mn - 239.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 239.79 Mn
Dec 31, 2025 16.26 Mn
Jun 30, 2025 51.97 Mn
Dec 31, 2024 26.33 Mn
Jun 30, 2024 92.26 Mn
Dec 31, 2023 135.76 Mn
Dec 31, 2022 -232.68 Mn